Characterizing immunological and genomic resistance mechanisms to anti-PD-1 immunotherapy in smoking-associated head and neck cancer
Ended Project Grant Awarded Last action
- Award ID
- W81XWH2210249
- Recipient
-
The Feinstein Institutes For Medical Research UEI C5LHMPRJ9J19
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $655,000
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- Manhasset, NY 11030, USA
Award details come from USAspending.gov.
About this award
The Feinstein Institutes for Medical Research was awarded a $655,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research characterizing immunological and genomic resistance mechanisms to anti-PD-1 immunotherapy in smoking-associated head and neck cancer. The grant period runs from April 15, 2022 to April 14, 2025. Through this funding, the Feinstein Institutes will investigate medical solutions for cancer on the battlefield and deliver applied biomedical research transforming healthcare for service members and the public.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $655,000 |
Quick answers
Who received award W81XWH2210249?
W81XWH2210249 was awarded to The Feinstein Institutes For Medical Research by Defense Health Agency (Department of Defense) on April 15, 2022.
How much is award W81XWH2210249 worth?
$655,000 has been obligated on W81XWH2210249.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award